批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1992/10/29 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/07/11 |
SUPPL-68(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2020/12/04 |
SUPPL-62(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2020/12/04 |
SUPPL-60(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2020/09/09 |
SUPPL-57(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2020/09/09 |
SUPPL-43(补充) |
Approval |
Labeling-Patient Package Insert |
UNKNOWN
|
|
|
| 2017/03/16 |
SUPPL-63(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2016/12/16 |
SUPPL-58(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/02/24 |
SUPPL-40(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/01/30 |
SUPPL-53(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/01/23 |
SUPPL-54(补充) |
Approval |
Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2014/06/09 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2013/09/27 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2013/09/10 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2013/03/25 |
SUPPL-48(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2011/07/28 |
SUPPL-35(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2010/10/15 |
SUPPL-36(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2005/10/28 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/11/17 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/05/23 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 2002/05/23 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 2002/04/26 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 2001/06/07 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2000/04/03 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1998/08/12 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1997/01/31 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1996/03/20 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1996/02/01 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1995/11/28 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1995/05/03 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1994/12/01 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1994/12/01 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1994/02/17 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:MEDROXYPROGESTERONE ACETATE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:150MG/ML; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020246 |
001 |
NDA |
DEPO-PROVERA |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
Yes |
Yes |
AB |
1992/10/29
|
PFIZER |
| 076553 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2004/07/28
|
HONG KONG |
| 077235 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2017/11/28
|
AMPHASTAR PHARMS INC |
| 077334 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2017/11/28
|
AMPHASTAR PHARMS INC |
| 210227 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2018/10/12
|
XIROMED |
| 210761 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2019/04/24
|
SUN PHARM |
| 210760 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2019/05/01
|
SUN PHARM |
| 212824 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2022/08/22
|
EUGIA PHARMA |
| 212844 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2022/08/31
|
EUGIA PHARMA |
| 214309 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2023/01/05
|
HIKMA |
| 215397 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2023/06/07
|
AMNEAL |